Strides Pharma Science Announces Changes in Board, Key Managerial Personnel, and Senior Management Team
Strides Pharma Science Limited announced significant changes to its Board of Directors, Key Managerial Personnel (KMP), and Senior Management Personnel (SMP), effective June 1, 2026. The changes follow a Board meeting held on May 18, 2026, and reflect efforts to strengthen executive management representation and professionalize the company's leadership structure.The Board approved the company's comprehensive succession planning framework, which includes the promotion of internal talent to key leadership roles.
Key Leadership Transitions
The management structure saw several material transitions:- Venkata Seetharama Raju Pakalapati (Ramaraju PVS): Currently the Chief Operating Officer, Ramaraju PVS was elevated to become a Board Member and designated as Executive Director of the Company, effective June 1, 2026. Concurrently, he is identified as KMP, effective June 1, 2026, and will cease to serve as SMP by the end of business hours on May 31, 2026.
- Aditya Arun Kumar: He was redesigned from Executive Director Business Development to Non-Executive Director (Non-Independent), effective June 1, 2026. Aditya will cease to hold the office of Executive Director and KMP by the end of business hours on May 31, 2026. His shift allows him to continue supporting the leadership in a non-executive oversight capacity.
New Senior Management Appointments
The company also announced two new nominations to the Senior Management Personnel list:- Nandini Matiyani: She was nominated as SMP, effective June 1, 2026. Nandini brings over two decades of experience in human resources and previously held senior HR leadership roles at organizations including RateGain, Wipro, and OnMobile Global.
- Ariff Khan: He was nominated as SMP, effective June 1, 2026. Ariff has been associated with Strides since May 2024 and brings over 26 years of experience in the pharmaceutical sector, having held roles at leading organizations such as Cipla, Wockhardt, and Novartis.
Updated Leadership Structures
Effective June 1, 2026, the updated lists for the Board of Directors, KMP, and SMP are as follows.Strides Board of Directors
| # | Name of the Director | DIN | Designation |
|---|---|---|---|
| 1 | Arun Kumar | 00084845 | Founder & Non-Executive Director; And Chairperson of the Board |
| 2 | Dr. Kausalya Santhanam | 06999168 | Independent Director |
| 3 | Mukta Arora | 07225715 | Independent Director |
| 4 | Homi Rustam Khusrokhan | 00005085 | Independent Director |
| 5 | Ameet Hariani | 00087866 | Independent Director |
| 6 | Subir Chakraborty | 00130864 | Independent Director |
| 7 | Aditya Arun Kumar | 06999081 | Non-Executive Director |
| 8 | Badree Komandur | 07803242 | Managing Director & Group CEO |
| 9 | Venkata Seetharama Raju Pakalapati (Ramaraju PVS) | 07500141 | Executive Director |
Updated Key Managerial Personnel (KMP)
| # | Name of the KMP | Designation |
|---|---|---|
| 1 | Badree Komandur | Managing Director & Group CEO |
| 2 | Venkata Seetharama Raju Pakalapati (Ramaraju PVS) | Executive Director |
| 3 | Vikesh Kumar | Group CFO |
| 4 | Manjula Ramamurthy | Company Secretary & Compliance Officer |
Senior Management Personnel (SMP)
| # | Name of the SMP | Designation |
|---|---|---|
| 1 | Umesh Kale | Chief Quality Officer |
| 2 | Dr. Chithambaram Muthulingam | Executive VP Research & Development |
| 3 | Sormistha Ghosh | Group GC, CRO & CSO |
| 4 | Nandini Matiyani | Executive VP HR |
| 5 | Sugeet Chopra | Executive VP - Supply Chain Management |
| 6 | Ariff Khan | Executive VP Manufacturing Operations |
| 7 | Amit Gupta | Senior VP - Taxation |
| 8 | Vikesh Kumar | Group CFO |
| 9 | Manjula Ramamurthy | Company Secretary & Compliance Officer |
The company confirmed that the updated list of KMPs and SMPs, along with its 'Policy for Determination of Materiality of Events and Information,' will be available on the company website.
STAR Stock Price Movement
Strides Pharma Science Limited shares today slipped by 0.75% to settle at ₹1141.7. The stock finished the trading session on a total traded volume of 644,863 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: